The short version of peptide purity fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-03-11. Anything still debated is marked as such rather than presented as settled.
Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.
No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.
Identity testing for a cyclic peptide of this size usually relies on reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The mass spectrum confirms molecular weight, while the chromatographic trace indicates the proportion of related impurities. Tandem mass spectrometry can provide sequence-level information when fragmentation data are compared against a reference standard. Nuclear magnetic resonance is sometimes used to confirm the lactam bridge, although it requires more material and greater operator expertise than routine chromatographic methods.
Lyophilised peptide powder is comparatively stable when kept dry, cold and protected from light. Once dissolved, the molecule is exposed to hydrolysis, oxidation and microbial growth, and degradation accelerates at higher temperatures and in alkaline solution. Repeated freeze-thaw cycles concentrate solutes and promote aggregation. Handling guidance for research peptides commonly clusters around freezer temperatures for powder and short refrigerated use for reconstituted solutions, with pH control and sterile technique applied throughout.
Verification of a purchased sample requires documentation linking a batch to a certificate of analysis, and that document should be read for the methods used rather than the headline purity figure. A single chromatographic percentage does not establish identity. Independent laboratories can perform identity and content assays, but no such test establishes that a product is suitable for human use. Claims about efficacy rest largely on small, early studies rather than on replicated controlled trials, and that gap remains open.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H69N15O9 | Free base; salt forms add to total mass |
| Molecular mass | About 1024 daltons | Calculated for the free base |
| Structural class | Cyclic heptapeptide | Contains D-phenylalanine and norleucine |
| Parent hormone | Alpha-melanocyte-stimulating hormone | Endogenous tridecapeptide of 13 residues |
| Receptor profile | Non-selective melanocortin agonist | Interacts with MC1R, MC3R, MC4R and MC5R |
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.
The peptide was developed during the 1980s by researchers investigating melanocortin signalling and skin pigmentation pathways. Early work focused on analogues of alpha-melanocyte-stimulating hormone that would resist enzymatic breakdown more effectively than the parent molecule. Melanotan-2 emerged from that programme as a shortened, cyclised variant. Reports describing its synthesis and receptor activity later appeared in the scientific literature. Commercial availability grew through unregulated channels rather than through pharmaceutical approval.
Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.
Lyophilised melanotan-2 is comparatively robust when kept dry, cold and dark, and a desiccated powder stored at minus twenty degrees Celsius or below is generally expected to retain its chemical integrity for extended periods. In solution the peptide is far less stable, with degradation proceeding through oxidation of tryptophan and histidine residues, hydrolysis adjacent to the lactam bridge, and aggregation at higher concentrations. Repeated freeze-thaw cycling accelerates loss of the parent peak. Working aliquots are therefore prepared once, held cold, and used without letting the stock return to ambient temperature.
Quality assessment of research-grade peptide rests mainly on reversed-phase high-performance liquid chromatography for purity and on mass spectrometry for identity confirmation. A single main peak above a stated threshold, commonly ninety-eight percent by peak area, is the usual release criterion applied by suppliers. Independent analyses commissioned by laboratories and consumer organisations have repeatedly reported discrepancies between label claims and measured content, including truncated sequences, residual trifluoroacetate, and lower-than-declared peptide mass. Those findings do not establish that every supplier is unreliable, but they indicate that purity figures printed on a vial are claims requiring verification rather than settled facts.
== Ecology == The diet of the arapaima consists of fish, crustaceans, fruits, seeds, insects, and small land animals that walk near the shore (such as mammals and birds). The fish is an air breather, using its labyrinth organ, which is rich in blood vessels and opens into the fish's mouth, an advantage in oxygen-deprived water that is often found in the Amazon River. This fish is able to survive in oxbow lakes with dissolved oxygen as low as 0.5 ppm. In the wetlands of the Araguaia, one of the most important refuges for this species, it is the top predator in such lakes during the low-water season, when the lakes are isolated from the rivers and oxygen levels drop, rendering its prey lethargic and vulnerable. Arapaima may leap out of the water if they feel constrained by their environment or harassed.
== Clinical data == In a 12 week randomised clinical trial, subjects receiving AOD9604 lost, on average, 1.8 kg more than those receiving placebo. Development of AOD9604 was halted following poor efficacy in a later 24 week trial.
genetic engineering Also genetic modification or genetic manipulation. The direct, deliberate manipulation of an organism's genetic material using any of a variety of biotechnology methods, including the insertion or removal of genes, the transfer of genes within and between species, the mutation of existing sequences, and the construction of novel sequences using artificial gene synthesis. Genetic engineering encompasses a broad set of technologies by which the genetic composition of individual cells, tissues, or entire organisms may be altered for various purposes, commonly in order to study the functions and expression of individual genes, to produce hormones, vaccines, and other drugs, and to create genetically modified organisms for use in research and agriculture.
Sources: en.wikipedia.org
{\displaystyle {\vec {E}}=-\nabla \phi =-{\frac {V_{0}}{d^{2}}}\left(z{\hat {z}}-{\frac {x{\hat {x}}+y{\hat {y}}}{2}}\right)=-{\frac {V_{0}}{d^{2}}}\left(z{\hat {z}}-{\frac {1}{2}}{\vec {\rho }}\right)}
== Business == Smart Factory: Incorporating Virtual Factory models and data-driven process intelligence, it improves manufacturing efficiency and leads factory automation engineering initiatives in North America for global affiliates. At the 'IoT Tech Expo 2026' held in San Jose, California,, LG CNS showcased 'Factova'—an intelligent factory optimization solution that applies AI, big data, and IoT across the entire manufacturing lifecycle. Furthermore, LG CNS became the first South Korean company to be selected as an official AI and IT services partner by Honeywell, jointly developing AI-powered factory automation and intelligence technologies to drive corporate AI Transformation (AX). Smart Logistics: LG CNS expands its logistics automation footprint from e-commerce to beauty, food, fashion, and defense sectors, providing intelligent logistics solutions. At 'MODEX 2026', North America's largest supply chain expo, the company unveiled its automated logistics robot, 'Mobile Shuttle'. Engineered to operate reliably in sub-zero environments down to -26°C, its flagship capability extends to cold-chain logistics for food and retail. Hundreds of these shuttle-robot-based automated systems are currently deployed at global affiliates' manufacturing facilities in North America. Enterprise Solutions: Integrating emerging digital technologies, LG CNS provides a proprietary suite of testing tools, middleware, and marketing technology platforms to modernize corporate business infrastructures.
India remained a member of the Commonwealth of Nations after becoming a republic in 1950. It strongly supported decolonisation in Africa and Asia in the 1950s, and played a leading role in the Non-Aligned Movement. Following a period of cordial relations in the 1950s, India and China went to war in 1962, resulting in a decisive military defeat for India. By 1967, however, India was able to fend off Chinese excursions into Sikkim. India has had uneasy relations with its western neighbour, Pakistan. The two went to war in 1947, 1965, 1971, and 1999. Three wars were fought over the disputed territory of Kashmir. After the 1965 war, India began to pursue close military and economic ties with the Soviet Union. By the late 1960s, the Soviet Union was India's largest arms supplier. China's nuclear test of 1964 and threats to intervene in support of Pakistan in the 1965 war caused India to produce nuclear weapons. India conducted its first nuclear weapons test in 1974 and carried out additional underground testing in 1998. India has signed neither the Comprehensive Nuclear-Test-Ban Treaty nor the Nuclear Non-Proliferation Treaty, calling both flawed and discriminatory. India maintains a "no first use" nuclear policy and possesses a nuclear triad as a part of its "Minimum Credible Deterrence" doctrine. Since the end of the Cold War, India has increased its economic, strategic, and military cooperation with the United States and the European Union. In 2008, a civilian nuclear agreement was signed between India and the United States.
Sources: en.wikipedia.org
No regulatory agency has authorised melanotan-2 as a medicine for any indication. It circulates mainly as a research chemical or through unregulated channels. As a result, identity, purity and content are not independently guaranteed.
Melanotan-1, also called afamelanotide, is a linear analogue with greater selectivity for MC1R and has received approval in some jurisdictions for a specific photosensitivity disorder. Melanotan-2 is cyclic, less selective, and reaches central receptors more readily. The two are often confused in online discussion despite different pharmacology and regulatory status.
Alpha-MSH is an endogenous tridecapeptide derived from pro-opiomelanocortin. Melanotan-2 reproduces its core receptor-binding sequence inside a shortened, stabilised ring. The result is a molecule with a longer effective half-life and higher potency than the parent hormone.
Mass spectrometry combined with liquid chromatography provides both molecular weight confirmation and a measure of related impurities. Tandem mass spectrometry adds sequence information. A purity percentage reported without a mass measurement does not confirm what the material is.